Literature DB >> 25378403

Metabolic control of Ca2+/calmodulin-dependent protein kinase II (CaMKII)-mediated caspase-2 suppression by the B55β/protein phosphatase 2A (PP2A).

Bofu Huang1, Chih-Sheng Yang1, Jeffrey Wojton1, Nai-Jia Huang1, Chen Chen1, Erik J Soderblom2, Liguo Zhang3, Sally Kornbluth4.   

Abstract

High levels of metabolic activity confer resistance to apoptosis. Caspase-2, an apoptotic initiator, can be suppressed by high levels of nutrient flux through the pentose phosphate pathway. This metabolic control is exerted via inhibitory phosphorylation of the caspase-2 prodomain by activated Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). We show here that this activation of CaMKII depends, in part, on dephosphorylation of CaMKII at novel sites (Thr(393)/Ser(395)) and that this is mediated by metabolic activation of protein phosphatase 2A in complex with the B55β targeting subunit. This represents a novel locus of CaMKII control and also provides a mechanism contributing to metabolic control of apoptosis. These findings may have implications for metabolic control of the many CaMKII-controlled and protein phosphatase 2A-regulated physiological processes, because both enzymes appear to be responsive to alterations in glucose metabolized via the pentose phosphate pathway.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII); Caspase 2; Metabolism; Mutagenesis; Phosphatase; Phosphorylation

Mesh:

Substances:

Year:  2014        PMID: 25378403      PMCID: PMC4276857          DOI: 10.1074/jbc.M114.585844

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Regulatory interactions of the calmodulin-binding, inhibitory, and autophosphorylation domains of Ca2+/calmodulin-dependent protein kinase II.

Authors:  R J Colbran; Y L Fong; C M Schworer; T R Soderling
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

2.  Identification of protein phosphatase 1 in synaptic junctions: dephosphorylation of endogenous calmodulin-dependent kinase II and synapse-enriched phosphoproteins.

Authors:  S M Shields; T S Ingebritsen; P T Kelly
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

3.  Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle.

Authors:  A Rokolya; H A Singer
Journal:  Am J Physiol Cell Physiol       Date:  2000-03       Impact factor: 4.249

4.  Regulatory domain of calcium/calmodulin-dependent protein kinase II. Mechanism of inhibition and regulation by phosphorylation.

Authors:  R J Colbran; M K Smith; C M Schworer; Y L Fong; T R Soderling
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

5.  Activation of type II calcium/calmodulin-dependent protein kinase by Ca2+/calmodulin is inhibited by autophosphorylation of threonine within the calmodulin-binding domain.

Authors:  B L Patton; S G Miller; M B Kennedy
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

6.  Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria.

Authors:  Yin Guo; Srinivasa M Srinivasula; Anne Druilhe; Teresa Fernandes-Alnemri; Emad S Alnemri
Journal:  J Biol Chem       Date:  2002-02-06       Impact factor: 5.157

7.  Metabolic activation of CaMKII by coenzyme A.

Authors:  Francis McCoy; Rashid Darbandi; Hoi Chang Lee; Kavitha Bharatham; Tudor Moldoveanu; Christy R Grace; Keela Dodd; Wenwei Lin; Si-Ing Chen; Rajendra P Tangallapally; Manabu Kurokawa; Richard E Lee; Anang A Shelat; Taosheng Chen; Douglas R Green; Robert A Harris; Sue-Hwa Lin; Rafael A Fissore; Roger J Colbran; Leta K Nutt
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

8.  CDC55, a Saccharomyces cerevisiae gene involved in cellular morphogenesis: identification, characterization, and homology to the B subunit of mammalian type 2A protein phosphatase.

Authors:  A M Healy; S Zolnierowicz; A E Stapleton; M Goebl; A A DePaoli-Roach; J R Pringle
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

9.  Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.

Authors:  Patrice Lassus; Ximena Opitz-Araya; Yuri Lazebnik
Journal:  Science       Date:  2002-08-23       Impact factor: 47.728

10.  Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis.

Authors:  John D Robertson; Mari Enoksson; Minna Suomela; Boris Zhivotovsky; Sten Orrenius
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  5 in total

Review 1.  LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.

Authors:  Christopher S Hong; Winson Ho; Chao Zhang; Chunzhang Yang; J Bradley Elder; Zhengping Zhuang
Journal:  Cancer Biol Ther       Date:  2015-04-21       Impact factor: 4.742

2.  Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease.

Authors:  Jing Tian; Lan Guo; Shaomei Sui; Christopher Driskill; Aarron Phensy; Qi Wang; Esha Gauba; Jeffrey M Zigman; Russell H Swerdlow; Sven Kroener; Heng Du
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

Review 3.  Metabolic Regulation of Apoptosis in Cancer.

Authors:  K Matsuura; K Canfield; W Feng; M Kurokawa
Journal:  Int Rev Cell Mol Biol       Date:  2016-07-30       Impact factor: 6.813

4.  PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.

Authors:  Chao Hu; Mengxia Yu; Yanling Ren; Kongfei Li; Dominic M Maggio; Chen Mei; Li Ye; Juying Wei; Jie Jin; Zhengping Zhuang; Hongyan Tong
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

Review 5.  PP2A and tumor radiotherapy.

Authors:  Xiao Lei; Na Ma; Lehui Du; Yanjie Liang; Pei Zhang; Yanan Han; Baolin Qu
Journal:  Hereditas       Date:  2020-08-26       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.